Divergent compensatory responses to high-fat diet between C57BL6/J and C57BLKS/J inbred mouse strains
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Impaired glucose tolerance (IGT) and type 2 diabetes (T2DM) are polygenic disorders with complex pathophysiologies; recapitulating them with mouse models is challenging. Despite 70% genetic homology, C57BL/6J (BL6) and C57BLKS/J (BLKS) inbred mouse strains differ in response to diet- and genetic-induced obesity. We hypothesized these differences would yield insight into IGT and T2DM susceptibility and response to pharmacological therapies. To this end, male 8-wk-old BL6 and BLKS mice were fed normal chow (18% kcal from fat), high-fat diet (HFD; 42% kcal from fat), or HFD supplemented with the PPARγ agonist pioglitazone (PIO; 140 mg PIO/kg diet) for 16 wk. Assessments of body composition, glucose homeostasis, insulin production, and energy metabolism, as well as histological analyses of pancreata were undertaken. BL6 mice gained weight and adiposity in response to HFD, leading to peripheral insulin resistance that was met with increased β-cell proliferation and insulin production. By contrast, BLKS mice responded to HFD by restricting food intake and increasing activity. These behavioral responses limited weight gain and protected against HFD-induced glucose intolerance, which in this strain was primarily due to β-cell dysfunction. PIO treatment did not affect HFD-induced weight gain in BL6 mice, and decreased visceral fat mass, whereas in BLKS mice PIO increased total fat mass without improving visceral fat mass. Differences in these responses to HFD and effects of PIO reflect divergent human responses to a Western lifestyle and underscore the careful consideration needed when choosing mouse models of diet-induced obesity and diabetes treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Turner, R. C. (1999) · JAMA · doi:10.1001/jama.281.21.2005 · Cited by 2,375 · cited 1×
“The initial treatment of T2DM typically consists of a combination of antihyperglycemic agents, including metformin, sulfonylureas, PPAR agonists, or thiazolidinediones (TZDs), and incretin-based therapies; however, this approach is associated with high secondary failure rates, and many patients will ultimately transit…”
BackgroundDiabetes in Asia: Epidemiology, Risk Factors, and Pathophysiology
Chan, J. C. N., Malik, V., Jia, W., Kadowaki, T., Yajnik, C. S., Yoon, K.-H., & Hu, F. B. (2009) · JAMA · doi:10.1001/jama.2009.726 · Cited by 1,997
Role of Nonexercise Activity Thermogenesis in Resistance to Fat Gain in Humans
Levine, J. A., Eberhardt, N. L., & Jensen, M. D. (1999) · Science · doi:10.1126/science.283.5399.212 · Cited by 997 · cited 1×
“In lean individuals who are challenged with chronic overfeeding, resistance to obesity was directly predicted by spontaneous increases in activity (25).”
BackgroundKeller, M. P., Choi, Y., Wang, P., Belt Davis, D., Rabaglia, M. E., Oler, A. T., Stapleton, D. S., Argmann, C., Schueler, K. L., Edwards, S., et al. (2008) · Genome Research · doi:10.1101/gr.074914.107 · Cited by 377
DIABETES MELLITUS IN AMERICAN (PIMA) INDIANS
Bennett, P., Burch, T., & Miller, M. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92303-8 · Cited by 338
Ackermann Misfeldt, A., Costa, R. H., & Gannon, M. (2008) · Diabetes · doi:10.2337/db08-0878 · Cited by 114 · cited 1×
“Results were expressed as the percentage of cells positive for all three stains relative to the total number of insulin-positive cells (2).”
Background
Cited by
Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution
Honce, R., & Schultz-Cherry, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01071 · Cited by 457
An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus
Heydemann, A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2902351 · Cited by 366
MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cells
Sims, E. K., Lakhter, A. J., Anderson-Baucum, E., Kono, T., Tong, X., & Evans-Molina, C. (2017) · Diabetologia · doi:10.1007/s00125-017-4237-z · Cited by 100
Self-citationMurine models provide insight to the development of non-alcoholic fatty liver disease
Reid, D. T., & Eksteen, B. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000128 · Cited by 26
“Within the C57 sub-strains, C57BLKS/J mice have been reported to gain less weight over 12 weeks of HFD treatment and have improved glucose tolerance compared with C57BL/6J mice although the strains share 70 % genetic homology((43)).”
BackgroundIbrahim, S., Johnson, M., Stephens, C. H., Xu, J., Moore, R., Mariani, A., Contreras, C., Syed, F., Mirmira, R. G., Anderson, R. M., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101289 · Cited by 18
“75 U/kg bodyweight of regular humulin-R insulin (Eli Lilly) [28].”
MethodSelf-citation
Metadata
- Authors
- Sims, E. K., Hatanaka, M., Morris, D. L., Tersey, S. A., Kono, T., Chaudry, Z. Z., Day, K. H., Moss, D. R., Stull, N. D., Mirmira, R. G., & Evans-Molina, C.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2013-12-15
- Volume
- 305
- Issue
- 12
- Pages
- E1495-E1511
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1971041352
- Cited by
- 50
- References
- 7
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.